Log off SitemapDisclaimer

Osteoarthritis pain is relieved with Matrifen® transdermal pain relief patch

Matrifen® from Nycomed relieves the pain of osteoarthritis and other severe chronic pain and it has fewer adverse effects than other similar products.

Matrifen® eases the pain of osteoarthritisOsteoarthritis
Matrifen® is a well documentet pain patch, that relieves the aches and pains of osteoarthritis.

>> More information on osteoarthritis and Matrifen®

Matrifen® is a transdermal fentanyl patch indicated for patients with severe chronic pain such as cancer pain and other chronic distressing pain.

It is beneficial for patients with respiratory depression, hypoventilation, cognitive impairment, peripheral diabetic neuropathy, osteoarthritis, rheumatoid arthritis and cancer pain and is approximately 50 to 100 times as potent as morphine.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Special features

To access the site you must confirm being a healthcare professional - use the link on the left side of this page

Mode of action video

An animation presenting the Matrifen® patch;
- Application
- Mode of action

Additional material

- Product details
- Pharmacokinetics
- Technical profile
Conversion tables for download 

- Oral morphine to Matrifen (100:1)
- Oral morphine to Matrifen (150:1)
- Potency table